|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1996-12-18
|
|
pubmed:abstractText |
The purpose of this study was to compare the efficacy and safety of treating mobile iliofemoral patients with deep venous thrombosis (DVT) with subcutaneous low-molecular-weight heparin (dalteparin sodium) either 200 IU/kg once-daily (group 1) or 100 IU/kg twice-daily (group 2).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0741-5214
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
774-82
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8918323-Aged,
pubmed-meshheading:8918323-Aged, 80 and over,
pubmed-meshheading:8918323-Bandages,
pubmed-meshheading:8918323-Chi-Square Distribution,
pubmed-meshheading:8918323-Dalteparin,
pubmed-meshheading:8918323-Female,
pubmed-meshheading:8918323-Femoral Vein,
pubmed-meshheading:8918323-Fibrinolytic Agents,
pubmed-meshheading:8918323-Humans,
pubmed-meshheading:8918323-Iliac Vein,
pubmed-meshheading:8918323-Incidence,
pubmed-meshheading:8918323-Injections, Subcutaneous,
pubmed-meshheading:8918323-Lung,
pubmed-meshheading:8918323-Male,
pubmed-meshheading:8918323-Middle Aged,
pubmed-meshheading:8918323-Pulmonary Embolism,
pubmed-meshheading:8918323-Thrombosis,
pubmed-meshheading:8918323-Time Factors
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Frequency of pulmonary embolism in patients who have iliofemoral deep vein thrombosis and are treated with once- or twice-daily low-molecular-weight heparin.
|
|
pubmed:affiliation |
Department of Dermatology, Ludwig Boltzmann Institute for Nuclear Medicine, Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
